EUVIMEDEUVIMED entdecken
Crossref

Implications of Amino Acid Metabolism and Transport Dysregulation in the Etiopathogenesis of Autism Spectrum Disorder: Metabolomic Evidence, Neurobiological Mechanisms and Therapeutic Perspectives

Raluca Maxim, Carmen Lupusoru

Bulletin of Integrative Psychiatry · 15.06.2026 · 109 (2) · 109-116

DOI: 10.36219/bpi.2026.2.09 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of Integrative Psychiatry, online erschienen am 15.06.2026. Verfasst von Raluca Maxim und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorder (ASD) is a clinically and biologically heterogeneous neurodevelopmental condition involving genetic, metabolic and environmental determinants [1, 2]. Increasing evidence suggests that dysregulation of amino acid metabolism and transport may contribute to ASD pathophysiology in selected biologically defined subgroups rather than representing a universal causal mechanism [2–5]. This narrative review synthesizes current evidence regarding amino acid abnormalities in ASD, with emphasis on metabolomic findings, branched-chain amino acids (BCAA), blood–brain barrier transport, neuroactive amino acids, sulfur amino acid pathways, oxidative stress and gut-related amino acid metabolism. Plasma metabolomic studies have identified amino acid dysregulation metabotypes associated with BCAA imbalance in a subset of children with ASD [2]. Inactivating mutations in BCKDK have been linked to BCAA depletion, autism, epilepsy and intellectual disability, supporting the concept of a potentially treatable metabolic form of ASD [3, 4]. In addition, impaired SLC7A5-mediated transport of large neutral amino acids across the blood–brain barrier has been shown to alter cerebral amino acid availability and induce autism-like neurobehavioral abnormalities in experimental models [5]. Neuroactive amino acids, including glutamate, glutamine, GABA, glycine and tryptophan, may influence excitation–inhibition balance and neurotransmission, although findings remain heterogeneous [6]. Altered methionine, cysteine and glutathione-related pathways further support a link between amino acid metabolism and oxidative stress in ASD [7]. Gut metabolomic findings also suggest that vitamin and amino acid metabolism may be associated with symptoms and neurodevelopmental outcomes in children with ASD [8]. Current evidence supports amino acid metabolism and transport dysregulation as a biologically plausible mechanism in ASD subgroups, with potential value for biomarker discovery and precision medicine approaches.

Zitieren

APA

Maxim, R., & Lupusoru, C. (2026). Implications of Amino Acid Metabolism and Transport Dysregulation in the Etiopathogenesis of Autism Spectrum Disorder: Metabolomic Evidence, Neurobiological Mechanisms and Therapeutic Perspectives. Bulletin of Integrative Psychiatry, 109(2), 109-116. https://doi.org/10.36219/bpi.2026.2.09

Vancouver

Maxim R, Lupusoru C. Implications of Amino Acid Metabolism and Transport Dysregulation in the Etiopathogenesis of Autism Spectrum Disorder: Metabolomic Evidence, Neurobiological Mechanisms and Therapeutic Perspectives. Bulletin of Integrative Psychiatry. 2026;109(2):109-116. doi:10.36219/bpi.2026.2.09

BibTeX
@article{Maxim2026,
  author = {Maxim, Raluca and Lupusoru, Carmen},
  title = {Implications of Amino Acid Metabolism and Transport Dysregulation in the Etiopathogenesis of Autism Spectrum Disorder: Metabolomic Evidence, Neurobiological Mechanisms and Therapeutic Perspectives},
  journal = {Bulletin of Integrative Psychiatry},
  year = {2026},
  volume = {109},
  number = {2},
  pages = {109--116},
  doi = {10.36219/bpi.2026.2.09}
}
Kostenlos starten →